To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
The new device, building by a team of Indian Institute of Science, Bengaluru, will keep the heart in good condition for about eight hours.
'There is no emergency of a third wave that we are rushing for booster doses.'
In a major setback in the search for AIDS cure, a child in the US, who was thought to have been cured of HIV after intensive drug therapy, has been found with detectable levels of the virus, scientists say.
'We are going ahead with the trials assuming what we have is the vaccine.' 'There is also a chance that what you have is not the vaccine. Then, you have to go back to the drawing board again.' 'So far, there has been no success in developing a good vaccine against coronaviruses.' 'That's why there are hundreds of trials going on at different stages in different parts of the world.'
Results from the first phase of the clinical trial of an Ebola vaccine suggests it is safe to use, Chinese scientists say.
However, in two different dose regimens, the vaccine's efficacy was 90 per cent in one and 62 per cent in the other.
Thanks to technological support provided by BlinkIN, a Bengaluru-based intelligent visual-assistance company, engineers in Wuhan were able to remotely install air ventilation systems in two hospitals in Wuhan, the epicentre of the coronavirus pandemic, reports Peerzada Abrar.
He invented a skin patch that can detect a silent heart attack 6 hours before it happens!
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.
Bhargava is a pioneer in the field of biotechnology in the country.
State Ayurved Department's licence officer Y S Rawat said the notice is being issued to the firm to explain from where it got the permission to launch a 'corona kit' as a cure from the virus.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
Chronic fatigue syndrome may have its origin in your gut, says Nikita Puri.
Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.
Germany's drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India's pharmaceutical research company GVK Biosciences were "insufficient".
What 32-year-old star Mandy Moore's actions tell us about anti-ageing regimes...
'There is no data to show this virus is more deadlier.'
Rediff.com Senior Contributor P Rajendran reports from New York on how the Indian-American researcher's pioneering work may wipe out the visible effect of Alzheimer's disease.
With these states imposing lockdowns anew, the health ministry emphasised that the restrictions should be utilised to focus on containment, surveillance and testing in the containment and buffer zones as the key strategy for early detection of cases and fatality management.
Dr Udgeath Dhir, director and head, Cardiothoracic and Vascular Surgeons, Fortis Memorial Research Institute, Gurugram, explains why you must take extra care of your heart.
A group of public health experts, including doctors from All India Institute of Medical Sciences and members from the national taskforce on COVID-19, have said that mass, indiscriminate and incomplete vaccination can trigger emergence of mutant strains and recommended that there is no need to inoculate those who had documented coronavirus infection.
Cambridge, Massachusetts-based Moderna's announcement comes just a week after Pfizer and Biontech said their COVID-19 vaccine candidate was found to be more than 90 per cent effective in preventing COVID-19 in participants.
IIT Kharagpur set to be a one-stop-shop for all your parents' 'doctor-engineer' dreams! :-)
To build one's political and ideological arguments on the dead bodies piling up outside our crematoriums is despicable and breaches the basic tenet of human civility, argues Vivek Gumaste.
The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.
The Delhi government has ordered a magisterial probe into the incident.
The non-viability of green crackers may pave the way for e-crackers.
'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'
The experts said there is a need to relook at the testing strategy in a way that it results in guiding the public health response and effectively limiting the spread of the disease.
On this Teachers Day, I once again bow my head as I remember all the teachers who had taught me in school, college, military academy, army courses and so on. But Ms Shantha Potty Aunty, this one more head bow is specially for you, admirably says Colonel K Thammayya Udupa (retd).
The United Kingdom government has pledged 20 million to support the "ChAdOx1 nCoV-19" coronavirus vaccine trial programme, with UK Health Secretary Matt Hancock saying the government would "throw everything at" finding a vaccine against the deadly virus.
The rate of doubling of COVID-19 cases has increased to 12.6 days
Unsurprised by the rising numbers, epidemiologists are concerned about the virus reaching rural and tribal areas where the health infrastructure is weak, reports Ruchika Chitravanshi.
For vaccination, online registration is mandatory. Thereafter, eligible beneficiaries will be informed on their registered mobile number about the nearest vaccination facility, and the date and time of vaccination.
A massive pan-India inoculation drive against COVID-19 was set in process on Tuesday with more than 56 lakh doses of the Covishield vaccine flown to 13 cities across India from Pune and taken to designated national and state-level stores amid tight security.
The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.
The third phase trial of Bharat Biotech's Covaxin began in the state on Friday and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt.
The Union home ministry has issued strict guidelines for the enforcement of the 21-day complete nationwide lockdown in the wake of the covid-19 pandemic, invoking the National Disaster Management Act which may result in imprisonment of up to two years for any violation. All government offices, the offices of state and Union territory governments, autonomous institutions, public corporations, commercial, private, industrial establishments shall remain closed, the guidelines issued by the ministry said.
'We are rolling out a vaccine when we don't even have the phase 2 trial results; forget about phase 3 trial results.' 'Why are we playing with people's lives?'
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances